Fisher & Paykel Highlights Innovative Products for Respiratory Care at MEDICA 2022
|
By HospiMedica International staff writers Posted on 16 Nov 2022 |
|
Fisher & Paykel Healthcare (F&P; Auckland, New Zealand) is presenting its innovative products for respiratory care at this year's MEDICA, the world's largest annual medical technology trade fair, which is taking place from 14-17 November in Düsseldorf, Germany.
At MEDICA 2022, Fisher & Paykel is exhibiting its AIRVO 2 humidified high flow therapy system designed to support patients throughout the care continuum. Its wide flow range (2 to 60 L/min) enables use both in the most intensive treatment (intensive care unit/emergency room) and at home. The system comes with an integrated flow generator is portable, eliminating the need for a supply via a loud, heavy compressor or for connection to a stationary gas supply. Also being presented at the event is the F&P 950, a premium class respiratory humidification system that is easy to set up and use, minimizes condensate and offers advanced protection. The F&P 950 system provides consistent humidity even in a wide range of environmental conditions and up to 70 L/min flow rate with Optiflow nasal high-flow therapy.
Fisher & Paykel is also exhibiting Evaqua, the world's first ventilation tubing technology that minimizes mobile condensate in the expiratory limb by diffusing water vapor across the tubing walls. Evaqua technology can potentially reduce the need for hose system interruptions. The advanced ventilation tubing system is user-friendly, reduces condensate build-up to promote a closed system and minimizes the need for intervention. Visitors to Fisher & Paykel’s booth at MEDICA 2022 can also experience the MR850 active respiratory gas conditioning system that ensures a multi-configurable solution for patients requiring respiratory support. The MR850 delivers high flow rates with a humidified gas mixture through the unique Optiflow nasal cannula. This means comfortable delivery of therapy that promotes patient compliance and potentially reduces the intensity of care. In addition, Fisher & Paykel is highlighting its F&P Nivairo full-face mask for non-invasive ventilation (NIV) alongside the Optiflow Junior 2 Nasal Interface which is a non-sealing interface specifically designed to address the flow needs and anatomical characteristics of neonates, infants and children on NHF therapy.
Related Links:
Fisher & Paykel Healthcare
Latest MEDICA 2022 News
- Huntleigh Exhibits Range of Vital Signs Monitoring Solutions at MEDICA 2022
- Owen Mumford Presents Cutting-Edge Capillary Blood Sampling Devices for POC Testing
- Noul Demonstrates AI-Driven On-Site Diagnostics Platform at MEDICA 2022
- KUKA Presents Robot-Based Assistance Systems at MEDICA 2022
- Heyer Medical Exhibits State-Of-The-Art Ventilators, Anesthesia Workstations and Surgical Lights
- Progetti Highlights Advanced Defibrillators for Emergency Medicine at MEDICA 2022
- LG Electronics Showcases State-Of-The-Art Surgical, Diagnostic and Clinical Monitors at MEDICA 2022
- World’s First Detachable 4K 8MP Handheld Camera for Telemedicine Showcased at MEDICA 2022
- EIZO Exhibits Complete New CuratOR Series of Surgical Monitors at MEDICA 2022
- Parker Labs Showcases Range of Ultrasound Equipment Cleaners and Disinfectants
- OptoMedic Demonstrates Range of Endoscopic Imaging Systems at MEDICA 2022
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
